Keyphrases
Acellular Dermal
10%
Anticancer Immune Response
7%
Anticoagulation Medication
10%
Autoimmune
7%
Autoimmune Disease
14%
Cancer Types
7%
Cancer-immunity Cycle
7%
Circulating Tumor Cells
100%
Comorbid Patients
10%
Complication Rate
10%
Cycle Development
7%
Deep Phenotyping
50%
Defect Depth
10%
Dermal Regeneration Template
50%
Disease-related
7%
Donor Site Morbidity
10%
Epithelial-mesenchymal Transition
67%
Event Occurrence
7%
Excision
10%
Flap Coverage
10%
Flow Cytometric Analysis
8%
Flow Cytometry
9%
Full-thickness Scalp Defects
10%
Further Surgery
10%
Gene Expression
9%
Genetic Determinants
7%
Genetic Variants
7%
Genome-wide Association Study
7%
Germline Genetic Variation
50%
Germline Genetics
7%
Head-and-neck Radiotherapy
10%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
High Risk
7%
Host Genetics
7%
Host Genome
7%
Host Immune Response
7%
Human Skin Cancer
10%
Immune Checkpoint
7%
Immune Checkpoint Inhibitor Therapy
7%
Immune Checkpoint Inhibitors
50%
Immune Function
7%
Immune Response
7%
Immune-related Adverse Events
50%
Immunomodulatory Factors
7%
Independent Risk Factors
10%
Induced Toxicity
50%
Integra
50%
IrAE
14%
Large Defects
10%
Local Flap
10%
Mass Cytometry
50%
Microfluidic Enrichment
9%
Minor Complications
10%
Nave
8%
Off-target Effects
7%
Parsortix
12%
Partial Thickness
10%
Patient Care
7%
Patient Identification
7%
Polygenic Risk Score
7%
Postoperative Infection
10%
Proteomics Characterization
50%
Retrospective Analysis
10%
Scalp Defect
20%
Scalp Reconstruction
50%
Single-cell Resolution
7%
Skin Graft
30%
Success Rate
10%
Surgical Reconstruction
10%
T Cell Activation
7%
Time to Healing
10%
Transition Profile
11%
Tumor
9%
Biochemistry, Genetics and Molecular Biology
Anticancer
16%
Autoimmunity
50%
Cell Count
8%
Cell Function
16%
Cell Lineage
8%
Flow Cytometry
16%
Gene Expression
19%
Genetic Determinism
16%
Genetic Divergence
50%
Genetic Variation
50%
Genetics
16%
Genome-Wide Association Study
16%
Germ Cell
50%
Germline
50%
Immune Checkpoints
75%
Immune Response
33%
Immunocompetent Cell
8%
Intravenous Immunoglobulin
16%
Mass Cytometry
50%
Mesenchymal-Epithelial Transition
91%
Overall Survival
5%
Polygenic Score
16%
Progression Free Survival
5%
Proteomics
50%
Signal Transduction
8%
Signaling Protein
8%
T Cell
16%
Tumor Gene
8%
Tumor Immunity
16%
Tumor Marker
8%
Medicine and Dentistry
Anticoagulation
16%
Biological Marker
7%
Circulating Tumor Cell
100%
DNA Template
50%
Donor Site
16%
Flow Cytometry
13%
Gene Expression
12%
Head and Neck Squamous Cell Carcinoma
100%
Head Radiotherapy
16%
Mass Cytometry
50%
Mesenchymal-Epithelial Transition
65%
Neck Radiotherapy
16%
Neoplasm
16%
Postoperative Infection
16%
Proteomics
50%
Reconstructive Surgery
16%
Regeneration
50%
Scalp
50%
Scalp Reconstruction
50%
Skin Cancer
16%
Skin Flap
16%
Skin Graft
33%
Skin Transplantation
16%